Search

Your search keyword '"Distler, J"' showing total 799 results

Search Constraints

Start Over You searched for: Author "Distler, J" Remove constraint Author: "Distler, J"
799 results on '"Distler, J"'

Search Results

103. S.6.1 β-catenin is a central mediator in SSc

108. Evidence of the Contribution of the X Chromosome to Systemic Sclerosis Susceptibility: Association With the Functional Irak1 196Phe/532Ser Haplotype

109. Association of the CD226 Ser307variant with systemic sclerosis: Evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis

110. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis

111. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

114. OP0142 FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS

116. OP0115 EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL

118. OP0135 INHIBITION OF HSP90 REDUCES PROGRESSION OF DERMAL FIBROSIS AND INDUCES REGRESSION OF ESTABLISHED EXPERIMENTAL DERMAL FIBROSIS INDUCED BY BLEOMYCIN

122. SAT0354 TYPE 3 INNATE LYMPHOID CELLS ARE KEY DRIVERS OF PSORIATIC ARTHRITIS

123. OP0195 VASCULARIZED THREE-DIMENSIONAL MODELS OF HUMAN SKIN FIBROSIS

125. FRI0262 INCREASED PLASMA LEVELS OF HSP90 ARE ASSOCIATED WITH MORE SEVERE LUNG AND SKIN INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS

126. AB1346-HPR REAL-WORLD EFFECTIVENESS AND PERCEIVED USEFULNESS OF SYMPTOM CHECKERS IN RHEUMATOLOGY: INTERIM REPORT FROM THE PROSPECTIVE MULTICENTER BETTER STUDY

130. Association of a KCNA5 gene polymorphism with systemic sclerosis–associated pulmonary arterial hypertension in the European Caucasian population

140. Vascularized Three-Dimensional Models of Human Skin Fibrosis

149. Long term outcomes of immunmodulatory drugs in SSc-ILD - data rom the German SSc network

150. Does anti-acid treatment influence disease progression in SSc-ILD? Data form the German SSc-network

Catalog

Books, media, physical & digital resources